|
|
Article: Study Finds Over Half of Patients on COX-2 Therapy Take Aspirin, Possibly Negating the Gastrointestinal Benefits Afforded by COX-2's.
- Article from:
- PR Newswire
- Article date:
- June 14, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Findings reported in a study published today in the Archives of Internal Medicine found that over half of patients within a predominantly retiree population taking COX-2 anti-inflammatory drugs on a long-term basis were also taking aspirin therapy for its cardio-protective benefit.
Previously published clinical research has shown that using aspirin along with COX-2 therapies can negate the gastrointestinal (GI) benefit of using COX-2's, one of the primary reasons for using these more costly medications.
Researchers at pharmacy benefit manager Express Scripts examined aspirin and other over-the-counter pain reliever use among COX-2 users from a large ...
Related newspaper, magazine, and journal articles:
|
|
Article: Express Scripts Study Links Use of Generic Drugs to ...
Business Wire;
July 12, 2007 ;
700+ words
... ... its kind, pharmacy benefit manager Express Scripts' researchers have established a link ... drug plan costs," according to Emily Cox, Ph.D., senior director of research at Express Scripts. Cox and coauthor Doug Mager also found that ...
|
|